PONVORY (Ponesimod)

• Obtain an electrocardiogram (ECG) in order to determine whether preexisting conduction abnormalities exist. In patients with certain pre-existing conditions, advice from a cardiologist needs to be sought and first-dose monitoring is recommended. 
• Life-threatening and rare fatal infections have occurred in association with other S1P receptor modulators. Prior to initiating treatment with ponvory tablets, results from a recent (i.e., within 6 months or after interruption of prior therapy) complete blood count (CBC) including lymphocyte count needs to be reviewed.
• Elevations of transaminases may emerge in Ponesimod-treated patients. Obtain transaminase and bilirubin levels, if not recently available (i.e., within the last 6 months) prior to initiation of Ponesimod.
• Patients who develop signs/symptoms suggestive of hepatic dysfunction, such as abdominal pain, unexplained nausea, vomiting, fatigue, anorexia, rash with eosinophilia, or jaundice or dark urine during therapy, should have hepatic enzymes checked. Ponesimod should be discontinued in case significant liver injury is confirmed.
• An increase in blood pressure with Ponesimod may occur after approximately 30 days of therapy initiation and persisted with continued therapy. Blood pressure needs to be monitored during treatment with Ponesimod and managed appropriately.
• Cases of basal cell carcinoma and other skin malignancies have been reported in patients treated with S1P receptor modulators, including ponesimod tablets. Periodic skin examination is required for all patients, specifically those with risk factors for skin cancer. 
• Ponesimod may be responsible for causing fetal harm. Because it takes around 7 days to eliminate Ponesimod from the body, women of childbearing age should use apt contraception to avoid pregnancy during and for 7 days after stopping Ponesimod treatment.
• Ponvory may increase the risk of macular edema. An ophthalmic assessment of the fundus, including the macula, is required in all patients prior to starting treatment and again at any time in case a patient reports any change in vision while on therapy with Ponvory.
• In case live attenuated vaccine immunizations are needed, administer at least 30 days prior to initiation of Ponesimod. Avoid the use of live attenuated vaccines during and for 7 to 14 days after treatment with Ponesimod.

What documents are required to import PONVORY to India?

PONVORY (ponesimod) tablets can be imported by patients or government hospitals on the name of the patients only. The following documentation is required to import the product:

1. Valid prescription from a qualified doctor.
2. Patients’ diagnostic reports.
3. Patients’ ID proof (issued by the government of India).

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription from the doctor.
• Import permit if applicable.

Is PONVORY available in India?

PONVORY (ponesimod tablets) is a prescription drug that legally requires a medical prescription to be dispensed.

Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input on:

• Availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.).
• Medicine Price.
• Finding genuine and reliable sources from Canada, Europe, USA, and Australia.
• Ensuring 100% transparency.

PONVORY can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

Urgent Meds can facilitate the supply of PONVORY (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +16478184196 for PONVORY tablet price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is able to source the PONVORY (Cancer Treatment Medicines) from across the globe and has the ability to supply. Urgent Meds offers its customers worldwide access to the best available treatment.

Urgent Meds is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Ponvory®?

Ponesimod is the Generic Name for the trade name drug Ponvory®.

What is the Manufacturer’s Name of Ponvory®?

Ponvory® is manufactured by Janssen Pharmaceuticals, Inc.

Is Ponvory® approved by the FDA?

Yes, Ponvory® is approved by the FDA. Date of approval: March 18, 2021.

What is Ponvory®?

Ponvory is a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, approved by the FDA for the treatment of adult patients with relapsing forms of multiple sclerosis (MS).

What is the dosage and form of Ponvory® supplied?

Ponvory® is supplied as Tablets: 2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg, and 20 mg for oral administration.

What are the most common side effects due to Ponvory®?

The most common side effects due to Ponvory® include hypertension, upper respiratory tract infection, and hepatic transaminase elevation.

How much does Ponvory® cost in India?

The Ponvory tablet cost in India is reasonably affordable. In order to procure this multiple sclerosis drug authentically, you can call or WhatsApp +16478184196.

What are the storage conditions of Ponvory®?

Store the tablets of Ponvory at 20 to 25°C (68 to 77°F); excursions permitted from 15 to 30°C (59 to 86°F). Store in the original package. Do not discard desiccant. Protect from moisture. Keep out of reach of children.

Is it safe to buy Ponvory® online?

Yes, in order to buy Ponvory tablets online, always look for an authentic, legitimate, WHO-GDP and ISO certified Pharmaceutical Wholesaler/Distributor/Supplier.